Mar 31, 2020
Notice of Annual General Meeting in Hexagon AB (publ)
Mar 31, 2020
Notice of Annual General Meeting of Shareholders in Enea AB (publ)
Mar 30, 2020
Sedana Medical Sees Increased Demand and Keeps Time Schedule
Mar 27, 2020
Annual General Meeting of Shareholders in Securitas AB
Mar 26, 2020
Oncopeptides Announces 26% Overall Response Rate of Melflufen in Triple-class Refractory Multiple Myeloma Patients From the Pivotal HORIZON Study
Mar 23, 2020
The Lancet Haematology Publishes Results From Oncopeptides' Multicenter, International Phase 1/2 Study (O-12-M1)
Mar 20, 2020
Oncopeptides Provides Update Regarding COVID-19 Impact on the Melflufen Clinical Program
Mar 17, 2020
Update on Ericsson's Annual General Meeting 2020 Addressing the Corona Virus
Mar 10, 2020
First Liver Cancer Patient Dosed in the MIV-818 Phase Ib Study
Mar 03, 2020
Industrifonden Participates in ShardSecure's Over-subscribed Seed Round
Feb 28, 2020
Notice of Annual General Meeting of Husqvarna AB (publ)
Feb 21, 2020
The Volvo Group Part of Swedish-Indian Collaboration for Increased Traffic Safety
Feb 12, 2020
Summons to the Annual General Meeting of Shareholders in Castellum AB (publ)
Jan 30, 2020
Q4 Incl. Full Year Report 2019
Jan 26, 2020
La Chine, deuxième plus grand producteur d'armes au monde
Jan 24, 2020
Oncopeptides will Host a Webcast on Monday, January 27th at 11.00 (CET)
Jan 16, 2020
Invitation to Press and Analyst Conference in Stockholm
Jan 13, 2020
Last Patient Included in Sedana Medical's Pivotal IsoConDa Study
Jan 07, 2020
Oncopeptides Strengthens its Regulatory Function by Appointing Karin Eklund Vanderpol as Head of Regulatory Affairs
Dec 20, 2019
NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study